Searched for
ALVOGEN
Alembic Pharma gets USFDA nod for generic Nitrofurantoin capsulesAccording to IQVIA, Nitrofurantoin capsules, USP (Macrocrystals), 25 mg, 50 mg and 100 mg have an estimated market size of USD 23 million f...- Dispute settlement gives this stock an edge over peers in pharma packKunal Dhamesha of Emkay Global raised his price target for the stock to Rs 1,000 and sees potential gain of Rs 45 per share from the settle...
- Natco Pharma soars 17% as path to launch Revlimid generic clearsNatco Pharma would be the first company to launch Revlimid (lenalidomide) in March 2022 as Dr Reddy’s settlement clears the path for the co...
- Unichem Lab shares rise over 12% after USFDA approval for hypertension drugShares of the drug firm gained 7.04 per cent to trade at Rs 164 on the BSE.
- Natco Pharma's marketing partner gets USFDA approval for chest pain tabletsNitroglycerin Sublingual Tablets had total annual sales of around USD 77.3 million.
- Lupin launches generic antidepressant tablets in USThe company has launched its Fluoxetine tablets USP in the strength of 60mg after having received an approval from the United States Food a...
- Buy Dr. Reddy's Laboratories, target Rs 3,350: Edelweiss Financial ServicesBuy Dr. Reddy's Laboratories Ltd. at a price target of Rs 3350.0 .
- ‘Nod to sell Opioid drug in US positive for Dr Reddy’s stock’The company can resume at-risk launch of Suboxone with favourable ruling from the appeals court.
- Natco's partner Alvogen gets nod for influenza drug in USIn December last year, Alvogen launched the first generic equivalent to oseltamivir phosphate capsules in the United States.
- Natco Pharma launches Tamiflu generic capsules in USThe company's capsules are generic versions of Roche's Tamiflu drug
- Natco Pharma gets USFDA nod for generic Budesonide capsulesThe company has received "final approval of abbreviated new drug application from the US Food and Drug Administration for generic version o...
- Natco Pharma surges 7% on drug approvalThe stock rose 7.33 per cent to hit a high of Rs 650.90 on BSE. Volumes more than doubled on the counter to 98,000 shares, compared with a ...
- Natco Pharma gets ANDA nod for Tamiflu's generic versionTamiflu is used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days.
- Natco settles patent suit with Gilead, others over TamifluNatco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.
- Strides Arcolab gets USFDA nod for its generic anti-bacterial capsulesStrides Arcolab plans to immediately launch the product through US-headquartered firm Alvogen on a profit sharing basis.
Load More
